45 Active Studies

Thyroid Cancer Clinical Trials Near You

Also searched as: thyroid carcinoma, thyroid tumor, papillary thyroid clinical trials

Find 45 actively recruiting thyroid cancer research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

45Active Trials
43+Locations
12,810Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Thyroid Cancer Clinical Trials

Thyroid Cancer clinical trials are recruiting across 43 cities. Here are the cities with the most active studies:

Thyroid Cancer Trial Phases

PHASE2(11 studies)
NA(10 studies)
PHASE1(5 studies)
PHASE3(2 studies)

25 research organizations are sponsoring thyroid cancer trials.

About Thyroid Cancer

Thyroid cancer develops in the thyroid gland and is the most common endocrine malignancy. Most thyroid cancers are highly treatable with excellent prognosis. Types include papillary, follicular, medullary, and anaplastic thyroid cancer.

Clinical trials are advancing new treatments for thyroid cancer. Currently, 45 studies are recruiting a combined 12,810 participants across the United States. Research is being conducted by 25 organizations including National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), M.D. Anderson Cancer Center, Washington University School of Medicine and 22 others.

2026 Thyroid Cancer Research Landscape

As of July 2026, the thyroid cancer clinical trial landscape includes 45 actively recruiting studies across 43 cities in the United States. These studies are collectively seeking 12,810 participants, with an average enrollment target of 285 per study.

The research spans multiple phases of development: 11 studies are in PHASE2, 10 studies are in NA, 5 studies are in PHASE1, 2 studies are in PHASE3. The presence of Phase 3 trials indicates that some thyroid cancer treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 25 different organizations, including National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), M.D. Anderson Cancer Center, Washington University School of Medicine, Icahn School of Medicine at Mount Sinai, Georgetown University, and 20 others. The large number of sponsors reflects significant research interest and investment in thyroid cancer treatment advancement.

Geographically, thyroid cancer trials are most concentrated in Houston, Texas (14 trials); Bethesda, Maryland (6 trials); New York, New York (5 trials); Philadelphia, Pennsylvania (5 trials); San Francisco, California (4 trials) and 7 other cities.

Featured Thyroid Cancer Studies

Highlighted recruiting studies for thyroid cancer, selected by enrollment size and research scope.

RecruitingNCT04969926

Natural History Study of Parathyroid Disorders

Background: Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid hormone (PTH) signaling. PTH, the main secretory product of parathyroid glands is responsible for regulation of calcium-phosphate homeostasis. Objective: i) To investigate the cause of parathyroid disorders ii) To describe evolution, nat...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· 3,000 participants· 1 location (Bethesda)
View full study details →
RecruitingNCT00001160

Studies on Tumors of the Thyroid

Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. O...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· 2,500 participants· 1 location (Bethesda)
View full study details →
RecruitingNCT04216732

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.

Sponsor: M.D. Anderson Cancer Center· 2,030 participants· 2 locations (San Francisco, Houston)
View full study details →

Frequently Asked Questions About Thyroid Cancer Clinical Trials

Are there thyroid cancer clinical trials near me?

Yes, there are 45 thyroid cancer clinical trials currently recruiting across 43+ cities in the United States, including Houston, Texas; Bethesda, Maryland; New York, New York. Browse the studies above to find one at a location convenient for you.

How do I join a thyroid cancer clinical trial?

To join a thyroid cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are thyroid cancer clinical trials free?

Yes, participation in thyroid cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of thyroid cancer treatments are being studied?

Current thyroid cancer clinical trials are testing a range of approaches across PHASE2 (11 studies), NA (10 studies), PHASE1 (5 studies), PHASE3 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 25 research organizations.

Is it safe to participate in thyroid cancer clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 17, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov